The use of psychiatric drugs and medicine as a treatment is on the rise and has been over a past number of decades.
This rise coincides with the increased number of mental disorders or labels that have been voted in by the psychiatric profession.
Psychiatry’s Diagnostic Statistical Manual or DSM, which lists all of the mental disorders, has been growing and growing with more and more mental disorders and diseases being introduced. These disorders are not the product of medical research and discovery but simply by voting, based on nothing more than opinion and popularity.
So why is the number of mental disorders on the increase? Simple! There is money to be made from selling psychiatric drugs and the DSM is the means to do it.
The DSM has been called a “Billing Bible” by some, meaning the psychiatric profession and the pharmaceutical industry working together, inventing more and more mental diseases that can be used to create psychiatric drugs for. Or vice versa. Create a mental disorder for a drug already on the market used for one mental illness, only to be repackaged for another mental illness.
MORE MENTAL DISEASES = MORE MONEY!
The Psychiatric And Pharmaceutical Industry Conflict Of Interest
Cases where pharmaceutical companies have been paying psychiatrists to promote and push their psychiatric drugs and anti-depressants to the public have been or are being investigated by officials and in some cases huge fines levied against companies like GlaxoSmithKline (GSK) for wrongdoing.